Article
Domain III of the envelope protein as a dengue vaccine target
28 Jan 2010
Abstract excerpt
A dengue vaccine should induce long-lasting, simultaneous protection to the four dengue viruses while avoiding the immune enhancement of viral infection. Domain III of the dengue envelope protein has been implicated in receptor binding, and is also the target of specific neutralizing antibodies. Domain III has emerged as a promising region for a subunit vaccine candidate. Here, we review the current state of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
